ONO-1101
Phase 2/3Completed 0 views this week 0 watching💤 Quiet
Interest: 38/100
38
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Postoperative Supraventricular Tachyarrythmia
Conditions
Postoperative Supraventricular Tachyarrythmia
Trial Timeline
Jun 1, 2001 → —
NCT ID
NCT00212654About ONO-1101
ONO-1101 is a phase 2/3 stage product being developed by Ono Pharmaceutical for Postoperative Supraventricular Tachyarrythmia. The current trial status is completed. This product is registered under clinical trial identifier NCT00212654. Target conditions include Postoperative Supraventricular Tachyarrythmia.
What happened to similar drugs?
10 of 20 similar drugs in Postoperative Supraventricular Tachyarrythmia were approved
Approved (10) Terminated (1) Active (10)
Hype Score Breakdown
Clinical
15
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00311038 | Phase 2 | Completed |
| NCT00212654 | Phase 2/3 | Completed |
| NCT00212680 | Phase 2 | Completed |
Competing Products
20 competing products in Postoperative Supraventricular Tachyarrythmia